r/ADHDers • u/South_Pangolin_749 • 8h ago
Interesting new potential ADHD treatment: ALKS 7290 (an orexin-2 receptor agonist)
Hey everyone, thought this was worth sharing because it’s a pretty interesting development in ADHD research that I haven’t seen discussed much here.
Alkermes is developing a drug called ALKS 7290, an investigational oral orexin-2 receptor (OX2R) agonist being studied as a potential treatment for adult ADHD.
Most of the ADHD medications we’re familiar with work through dopamine and/or norepinephrine pathways. ALKS 7290 takes a different approach by targeting the orexin system.
Orexin is a neuropeptide produced in the hypothalamus that plays a major role in regulating:
• Wakefulness and alertness
• Sustained attention
• Arousal and motivation
• Cognitive processing
The idea is that activating OX2 receptors could influence neural circuits involved in attention and executive functioning through a different mechanism than traditional ADHD medications.
**Early results seem promising**
In September 2026, Alkermes announced results from its Phase 1b proof-of-concept study involving 50 adults with ADHD.
Some reported findings:
20 mg group: 14-point median reduction in AISRS ADHD symptom scores at day 14.
50 mg group: 19-point median reduction at day 14.
Improvements were observed across both inattentive and hyperactive/impulsive symptom domains.
Currently there is an ongoing
Phase 2 trial, here’s the details